The Amniotic Membrane Market, estimated at USD 4.62 Bn in 2025, is expected to exhibit a CAGR of 13% and reach USD 10.87 Bn by 2032.
The market growth is fueled by rising demand for advanced biotechnology solutions that improve healthcare outcomes, along with increasing adoption in areas such as drug development, diagnostics, and personalized medicine. Innovations in genomics, cell and gene therapies, and biomanufacturing, supported by strong R&D investments, are enhancing treatment effectiveness, efficiency, and accessibility. Furthermore, favorable regulatory support, strategic collaborations, and the growing focus on precision medicine are accelerating market expansion and opening new opportunities for industry participants.
Key market players are focusing on adopting growth strategies such as collaboration, agreement to increase their market footprint, which is expected to propel market growth over the forecast period. For instance, on January 11, 2023, Celularity Inc., a U.S.-based biotechnology company developing placental-derived allogenic cell therapies and biomaterial products, and CH Trading Group LLC, an international import, export, and trading company, announced that they had entered into an exclusive territory distribution agreement. CH Trading Group will act as the exclusive territory distributor of Celularity products. Celularity’s suite of biomaterial products includes Biovance, a decellularized, dehydrated human amniotic membrane derived from the placenta of a healthy, full-term pregnancy. Biovance 3L and Biovance 3L Ocular, tri-layer human amniotic membrane products focused on the surgical and ocular markets and available in both sheet and disk form.
Global Amniotic Membrane Market– Impact of Coronavirus (COVID-19) Pandemic
The World Health Organization (WHO) designated the illness caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), which first appeared in Wuhan (province of Hubei, China) in the last months of 2019, as "coronavirus disease 2019" or COVID-19. This virus spread quickly and had a serious negative impact on the economies, social behaviors, and healthcare of every country in the world.
COVID-19 affected the economy in three main ways: by directly affecting production and demand, by creating disruptions in distribution channels, and through its financial impact on firms and financial markets. Due to the lockdown, several countries, such as India, China, Brazil, and others, faced problems with regard to the transportation of things from one place to another.
COVID-19 had a negative impact on the global amniotic membrane market. For instance, according to an article published in the Nature scientific journal in June, 2020, the amniotic membrane of COVID-19-positive females were tested to be positive for COVID-19 infection. Hence, the article suggests medical practitioners carry out COVID-19 testing on asymptomatic amniotic membrane donors.